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Increasing evidence links long-term exposure to ambient particulate matter with an aerodynamic diameter less than or equal to 2.5 µm (PM 2.5 ), also called fine particulate matter, to elevated risk of lung cancer (1). Pope et al. (2) reported that each 10-µg/m 3 increase in average PM 2.5 concentration (1979-1983) was associated with an 8% (95% confidence interval (CI): 1, 16) increase in the risk of lung cancer mortality in the American Cancer Society's Cancer Prevention Study II (CPS-II). Krewski et al. (3) reported similar results using an extended 18-year follow-up period (an 8% increase in risk per 10-μg/m 3 increase in PM 2.5 (95% CI: 3, 14)). Results from other recent studies also support a PM 2.5 -lung cancer association (4, 5) . Based on current observational and mechanistic evidence, the International Agency for Research on Cancer (Lyon, France) recently classified both outdoor air pollution and airborne particulate matter as carcinogenic to humans (Group 1) (6).
This conclusion notwithstanding, there remain important gaps in the epidemiologic literature on the role of air pollution in lung cancer risk, including the assessment of possible joint effects of cigarette smoking and PM 2.5 exposure on lung cancer risk. Such information is useful from a public health perspective to better understand the total burden of disease associated with these highly prevalent lung cancer risk factors and the impact of interventions designed to reduce exposure to either risk factor. Although some earlier studies suggested that the joint effects of smoking and air pollution may be greater than additive, to our knowledge no major cohort study has provided estimates of interaction between smoking and air pollution on the additive scale, which is most relevant for population health risk assessment (7, 8) .
In this analysis, we examined interactions on the additive scale between 2 major lung cancer risk factors, cigarette smoking and PM 2.5 exposure, in CPS-II. This large-scale cohort study has been instrumental in increasing understanding of the main effects of both risk factors and afforded us a unique opportunity to examine their possible interaction.
METHODS

Study population
CPS-II is a prospective cohort study of nearly 1.2 million participants enrolled by over 77,000 volunteers in 1982. Ethics approval for CPS-II was obtained from the Emory University School of Medicine (Atlanta, Georgia) Human Investigations Committee. Participants were recruited in all 50 US states as well as the District of Columbia and Puerto Rico. Participants were largely friends and family members of the volunteers. For inclusion in CPS-II, participants had to be at least 30 years of age and have at least 1 family member aged 45 years or older. A 4-page self-administered questionnaire completed at the time of enrollment collected data on a range of demographic, lifestyle, medical, and other factors, including place of residence.
Follow-up for vital status has been conducted every 2 years. In 1984, 1986, and 1988, information on vital status was obtained from the study volunteers, and deaths were confirmed by obtaining death certificates. Since 1989, computerized linkage to the National Death Index has been used for follow-up (9) . For the present analysis, however, follow-up was truncated at the first 6 years in order to classify participants by cigarette smoking status, because updated information on cigarette smoking status was not collected after enrollment (10) . Over 99% of all known deaths have been assigned an underlying cause. Lung cancer deaths were classified according to the underlying cause of death using the International Classification of Diseases, Ninth Revision (11), coding system (code 162).
Of the 1,184,588 CPS-II participants, we excluded persons with invalid address information (n = 385,422) and persons with missing data on vital status or other individual-level covariates of interest (n = 130,119), as well as former cigarette smokers (n = 172,690) and persons who had ever smoked a pipe or cigars (n = 66,951). A total of 429,406 participants were retained for analysis. A total of 1,921 lung cancer deaths were observed in 2,509,717 person-years of follow-up.
Exposure to PM 2.5 Estimated ambient PM 2.5 concentrations were linked to the geocoded home addresses of CPS-II participants at enrollment in 1982 using a national-level hybrid land use regression (LUR) and Bayesian maximum entropy (BME) interpolation model (12) . Monthly PM 2.5 data were available from 1999 to 2008 for a total of 1,464 monitoring locations. In the first stage, a LUR model using a deletion/substitution/addition algorithm predicted PM 2.5 concentrations based on 2 variables: vehicular traffic at 1,000 m (based on modeled traffic counts) and green space at 100 m cubed. In the second stage, a BME interpolation model was used to capture residual spatiotemporal variation in PM 2 
Statistical analysis
Cox proportional hazards regression models were used to obtain adjusted hazard ratios and 95% confidence intervals for associations with lung cancer mortality. The proportional hazards models were stratified by age (1-year categories), sex, and race (white, black, or other). Follow-up time since enrollment (1982) was used as the time axis. Survival times of persons who were still alive at the end of follow-up were censored. Dichotomous indicators for cigarette smoking (current smoker at enrollment vs. never smoker at enrollment) and PM 2. 2 ); body mass index squared; secondhand smoke exposure ("passive smoking"; hours/day); quintiles of vegetable, fruit, fiber, and fat intake; alcohol consumption (beer, wine, and liquor); occupational exposures (asbestos, chemicals/ acids/solvents, coal or stone dusts, coal tar/pitch/asphalt, formaldehyde, and diesel engine exhaust); and a previously developed "occupational dirtiness index" (13) .
On the additive scale, effect modification was assessed according to the relative excess risk due to interaction (RERI), the attributable proportion due to interaction (AP), and the synergy index (S). The RERI is defined as relative risk (RR) 11 − RR 10 − RR 01 + 1, the AP as RERI/RR 11 , and the S as (RR 11 − 1)/ (RR 10 + RR 01 − 2). These variables were calculated according to the "MOVER" method for the analysis of 4 × 2 tables with associated 95% confidence intervals (14) . RERI and AP values of 0 and S values of 1 indicate no interaction. On the multiplicative scale, interaction terms for interaction between cigarette smoking and PM 2.5 concentrations were entered into the proportional hazards regression models. Two-sided P values were calculated to assess the significance of the interaction term using the likelihood ratio statistic. All statistical tests were 2-sided. Analyses were conducted using SAS, version 9.2 (SAS Institute, Inc., Cary, North Carolina) (15). Ethics approval for the statistical analysis was obtained from the Ottawa Hospital (Ottawa, Ontario, Canada) Research Ethics Board. greater than high school (Table 1) . Lung cancer mortality rates varied according to cigarette smoking status and PM 2.5 exposure (Appendix Table 1 ). The difference in lung cancer mortality between never cigarette smokers and current cigarette smokers was greater with higher PM 2.5 concentrations.
Hazard ratios for current cigarette smokers as compared with never smokers ranged from 13 Table 1) , depending on the categorical indicator of cigarette smoking and PM 2.5 concentration, indicating small increases in risk among persons with both exposures compared with that expected based on the sum of the individual exposures alone. The AP ranged from 0.04 (95% CI: −0.06, 0.13) to 0.14 (95% CI: 0.00, 0.25), and S ranged from 1.05 (95% CI: 0.94, 1.17) to 1.17 (95% CI: 1.00, 1.37).
In sensitivity analyses, the RERI, AP, and S also generally increased when using the 25th and 75th percentiles as cutpoints for PM 2.5 in men (RERI = 4.64, 95% CI: −2.18, 14.75; AP = 0.17, 95% CI: 0.00, 0.31; S = 1.22, 95% CI: 1.00, 1.48), participants reporting less than 3 hours of daily exposure to secondhand tobacco smoke (RERI = 3.09, 95% CI: −0.50, 7.24; AP = 0.18, 95% CI: −0.03, 0.35, S = 1.24, 95% CI: 0.97, 1.58), and heavy (≥20 pack-years) cigarette smokers (RERI =2.68, 95% CI: −0.17, 6.02; AP = 0.14, 95% CI: 0.00, 0.26; S = 1.17, 95% CI: 1.00, 1.37).
On the multiplicative scale, estimates of interaction ranged from 0.81 (95% CI: 0.59, 1.10) to 0.93 (95% CI: 0.65, 1.33), indicating a joint effect somewhat smaller than the product of the individual exposures, but these estimates were imprecise ( Table 2, Web Table 1 ). Similar results were obtained when adjusting for mean county-level residential radon concentrations or 1980 sociodemographic ecological covariates (16, 17) .
DISCUSSION
In this study, we examined the interaction between cigarette smoking and PM 2.5 for lung cancer mortality on the additive scale in CPS-II. This scale is generally considered to be most appropriate for purposes of population health risk assessment (8) . Small increases in risk among persons with both exposures were observed beyond what would be expected from the sum based on individual exposures alone. Estimates of the RERI, AP, and S were 2.19 (95% CI: −0.10, 4.83), 0.14 (95% CI: 0.00, 0.25), and 1.17 (95% CI: 1.00, 1.37), respectively, using cutpoints of the 25th and 75th percentiles for PM 2.5 . Results suggest a combined effect for lung cancer mortality among cigarette smokers with high PM 2.5 exposure 2.2 times greater than expected based on the addition of results for cigarette smoking and PM 2.5 alone. Results also suggest that approximately 14% of lung cancer mortality among cigarette smokers with high PM 2.5 exposure may be due to interaction of the 2 factors. Previous studies indicated some evidence for departures from additivity (7). On the multiplicative scale, a joint effect somewhat smaller than the product of the individual exposures was observed, but results were imprecise.
Examining interactions among environmental exposures, even 2 well-characterized carcinogens assessed in a large cohort, is challenging. Tests for interaction are typically low in statistical power, and the resulting interaction estimates are imprecise (18) . Despite the large size of the CPS-II cohort, there was limited power to detect interactions in a range that was relevant to population health. Statistical power was limited by the necessary restriction of follow-up (the first 6 years), which reduced the number of lung cancer deaths. However, we also used a new national-scale spatiotemporal PM 2.5 LUR-BME model, expanding the included study population beyond those residing only in US Census Metropolitan Statistical Areas with central monitoring data, capturing variability in PM 2.5 concentrations both within and between Metropolitan Statistical Areas (3). Although the time period spanned by the PM 2.5 LUR-BME data was beyond the follow-up time period of the cohort, PM 2.5 concentrations over the past several decades are correlated (19) . Moreover, exposure estimates are subject to information bias. While cumulative exposure to tobacco smoke can be estimated by questionnaire, lifetime exposures to air pollution cannot be readily estimated from CPS-II data. PM 2.5 concentrations were also low. We explored various PM 2.5 cutpoints for assessing interaction. The RERI, AP, and S increased with increasing PM 2.5 cutpoint. Potential biological mechanisms for a greater-than-additive effect remain unclear, although there are multiple ways in which smoking can interact with other agents for which exposure occurs by inhalation (20) . PM 2.5 dose from ambient air pollution is significantly lower than that from cigarette smoking (10) . Lung cancer risk is a function of the various carcinogenic substances transported on the particles (21), which may exhibit differential levels of toxicity (22) . Results may also be due to chance, differences in timing of exposure, or differences in exposure levels.
In sum, although reductions in cigarette smoking will achieve the greatest impact on lung cancer rates, these results do not rule out the possibility that reductions in lung cancer burden by means of both tobacco control and air quality management may actually be greater than current estimates of the effect of reducing exposure to either risk factor alone. Results are also important for estimates of the global burden of disease, which currently assume independence of PM 2.5 -related excess mortality across categories of cigarette smoking status (23) . We thank Drs. Richard T. Burnett and Charles Poole for helpful comments. 
